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Abstract
Development of neural network models for the prediction of glucose levels in critically ill patients through the
application of continuous glucose monitoring may provide enhanced patient outcomes. Here we demonstrate the
utilization of a predictive model in real-time bedside monitoring. Such modeling may provide intelligent/directed
therapy recommendations, guidance, and ultimately automation, in the near future as a means of providing opti-
mal patient safety and care in the provision of insulin drips to prevent hyperglycemia and hypoglycemia.
Background
Following severe trauma, approximately 25% of patients
experience hyperglycemia [1]. Sustained hyperglycemia
increases mortality and increases care needs [2-4]. How-
ever, lowering glucose levels after severe trauma may
decrease mortality, days of ventilation, incidence of
infection, and length of stay in an intensive care unit
(ICU) and in the hospital [2-5]. Aggressive therapy to
maintain glucose levels below 150 mg/dl improves out-
comes [3]. Glucose levels exceeding 200 mg/dl in
severely injured patients have been correlated to an
increase in mortality [2]. In addition to trauma patients,
cardiothoracic surgical patients also experience lack of
glycemic control during all phases of the perioperative
period. Persistently elevated glucose values in this
patient base have also been linked to adverse outcomes
and increases in mortality [6-8].
The standard method for management of glycemic
control in critical care patients is adjustment of a variable
infusion of insulin on the basis of discrete point of care
(POC) blood glucose monitoring via handheld glucose
meters [9]. This POC monitoring is completed every 1-4
hours throughout a patient’sl e n g t ho fs t a yi nt h eI C U .
Based on POC glucose values, insulin is infused intrave-
nously to maintain a normal glycemic state. This practice
is limited as POC monitoring only provides glucose
values when measurements are obtained every 1-4 hours.
Patients may be hyperglycemic or hypoglycemic between
POC results. Recent advances in technology include the
development of real-time continuous glucose monitoring
(CGM) devices which report measurements of interstitial
glucose concentration every few minutes. A recent inves-
tigation studied the impact of utilizing real-time CGM in
the critical care setting [10]. The study concluded that
utilization of CGM did not correlate to a direct benefit in
patient outcome. However, utilization of CGM did corre-
late with improvement of glycemic control in patients
with high sequential organ failure (SOFA) scores, and
increased the ability of caregivers to mitigate occurrences
of hypoglycemia. It is important to note that CGM
devices were utilized only for documentation of glucose
values and were not used in a predictive capacity. Utiliza-
tion of CGM devices in combination with predictive
models for glucose may provide clinicians with a means
for enhancement of glycemic control and patient out-
come. Given the limitations of POC monitoring there is a
need to develop technologies to allow critical care provi-
ders access to predicted glucose values thereby allowing
optimization of glycemic control. The prediction of glu-
cose in outpatients with insulin dependent diabetes via a
neural network modeling approach has been previously
demonstrated [11]. This report is an extension of the pre-
vious application, and involves the development and
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diction of glucose in critical care patients. Such networks
have the ability to quantify the effect of various factors
on a desired predicted variable. Neural network modeling
is therefore well suited in such a venue, where various
factors such as, but not limited to, medications, vital
signs, nutritional intake, and ventilation data are routi-
nely collected in a controlled setting. Construction of a
neural network model for prediction of glucose in the
critical care setting requires a large dataset for model
training and development. The utilization of CGM pro-
vides a significant and suitable source of glucose data for
neural network model development. Such a dataset is
superior to a dataset containing only discrete POC
values. Furthermore, this allows for assessment of trends
in glucose which cannot be distinguished in POC glucose
monitoring results.
Methods
Patient Data Acquisition and Development of Patient
Specific and General Neural Network Models for
Prediction of Glucose in the Critical Care Setting
After institutional review board approval a patient
specific neural network model was developed/trained
using 243.6 hours (2,923 data points) of continuous
glucose monitoring (CGM) (Medtronic Diabetes,
CGMS Ipro®) and concurrent medical records data
from a 38 year old trauma patient (who had an
intensive care stay of 16 days). The model was config-
ured for prediction of glucose by implementing a pre-
diction horizon of 75 minutes. Additionally, a general
feed forward neural network was developed/trained
using 515.7 hours (6,188 data points) of CGM and
medical records data from 5 critical care patients and
configured with the same 75 minute prediction
horizon.
Neural Network Model Design and Training
The neural network models were trained via the back-
propagation training algorithm. In this training modality,
model error is calculated, and model weights for mini-
mization of this error can be determined. The neural
network models were designed with a three layer design.
The input layer of the neural network was configured to
utilize time, CGM data, and electronic medical records
that included point of care glucose test times and
results, insulin delivery type (intravenous drip, or subcu-
taneous sliding scale), and units of insulin delivered as
input variables for prediction. The second or hidden
layer of the neural network was designed to limit the
range of neural network model inputs to between -1
and 1. This enables data within the neural network to
be more easily processed and for trends in data to be
identified more effectively. Figure 1 includes the neural
network model architecture and dataflow in generation
of model predictions.
Figure 1 Neural network architecture and data flow.
Pappada et al. Patient Safety in Surgery 2010, 4:15
http://www.pssjournal.com/content/4/1/15
Page 2 of 5Neural Network Model Performance Analysis and
Validation
A computer program implementing the neural network
model for real-time prediction of glucose was developed.
Data from the trauma patient not utilized for initial model
development/training (containing 40.3 hours [484 data
points] of CGM and medical records) was used to test the
performance of the patient specific and general neural net-
work models. Clarke Error Grid Analysis (CEGA) was
completed to assess clinical acceptability of real-time pre-
dictions. Overall error (mean absolute difference percent
[MAD%]) was calculated for real-time predictions.
CEGA was established in 1987 and was originally uti-
lized to assess patient estimates of blood glucose com-
pared to those obtained using a “gold-standard”
reference glucose meter [12]. The accuracy of current
C G Mt e c h n o l o g i e si sa l s oa s s e s s e dv i au t i l i z a t i o no f
CEGA to compare CGM performance to that of blood
glucose meters. Region A contains predicted values
within 20% of the reference concentration and Region B
contains predictions outside 20%. However, Region B
predicted values would not lead to inappropriate treat-
ment. Regions A and B therefore contain predicted
values which can be classified as clinically acceptable.
Region C contains points that lead to unnecessary treat-
ments, and Region D contains points indicating a poten-
tially dangerous failure to detect hypoglycemia. Region E
contains predicted values that would confuse treatment
of hypoglycemia for hyperglycemia and vice-versa. A
successful predictive model and system would thus need
a majority of predicted CGM values to fall with regions
A and B in the Clarke Error Grid. If a majority of pre-
dicted values fall within regions A and B of the Clark
Error Grid, any therapeutic interventions made using
the NNM predictive results would not lead to any
adverse or unwanted glycemic excursions.
Analysis of the Clinical Applicability and Usefulness of
CGM and Neural Network Model for Prediction of Glucose
in the Trauma Patient
In addition to performance analysis of the neural net-
work model, the utility of CGM in the trauma patient
was analyzed. This was accomplished by determining
the percentage of hypoglycemic (≤70 mg/dl) and hyper-
glycemic (≥150 mg/dl) events that were detected by
CGM and not by conventional POC glucose monitoring.
In this analysis we locate hypoglycemic and hyperglyce-
mic CGM values and search for POC monitoring values
within a defined time window. A time window of
60 minutes is defined as 30 minutes before and 30 min-
utes after the detected extreme. If there is a POC value
within the time window it is defined as a successful
detection of hypoglycemia/hyperglycemia via POC mon-
itoring. Table 1 demonstrates the usefulness of CGM in
detecting hypoglycemic and hyperglycemic glucose
values which are not detected via conventional POC
monitoring. This table summarizes the percentage of
hypoglycemic/hyperglycemic CGM values detected via
POC monitoring.
Results
Throughout the patient’sl e n g t ho fs t a yi nt h eI C U ,
CGM detected a total of 642 hyperglycemic and 124
hypoglycemic occurrences. The patient was on an insu-
lin drip throughout their length of stay in intensive care
and POC glucose monitoring was completed intensively.
Table 1 indicates that the prediction horizon of 75 min-
utes implemented in the NNMs is likely ideal for this
patient population and will provide insight where POC
glucose values are not obtained.
Figure 2 includes the real-time predictions on the test
dataset using the patient specific neural network model.
Due to the large dataset of 7,260 predicted glucose
values (i.e. 15 CGM values predicted for every CGM
value in the test dataset) the data was re-sampled to
demonstrate predictive accuracy in Figures 2 and 3. Re-
sampling involved plotting every 20th predicted CGM
value and corresponding actual glucose value in the pre-
dictive dataset. The overall error (MAD%) of the predic-
tions generated using the patient specific model was
calculated as 7.9%.
Figure 3 includes the real-time predictions on the test
dataset using the general neural network model. The
overall error (MAD%) of the predictions generated using
the general model was calculated as 15.9%. The patient
specific model therefore generates more accurate predic-
tions with a decrease in overall error of 8.0%.
Figure 4 is the Clarke Error Grid showing the real-
time predictions generated via the patient specific neural
network model. CEGA revealed that 95.1% of the pre-
dictions fell within region A of the error grid and 4.9%
fell within region B of the error grid. Figure 5 is the
Clarke Error Grid showing the real-time predictions
generated via the general neural network model. CEGA
revealed that 69.8% of the predictions fell within region
A of the error grid and 30.2% fell within region B of the
error grid. In both instances 100% of the predicted
CGM values could be considered clinically acceptable
with no predicted values falling within regions C, D, or
Table 1 Percentages of hyper-and hypoglycemia detected
by point-of-care testing
Glucose % Detected % Detected at % Detected at
Range at 40 min 60 min 80 min
Hyper 51.4 74.0 96.9
Hypo 61.3 91.9 100.0
min = minutes; % = percentage; hyper = hyperglycemia; hypo =
hypoglycemia
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specific model generated predictions with a high degree
of accuracy as 95.1% of the values fell within region A
of the error grid and had values within 20% of the refer-
ence glucose concentration.
Discussion
The real-time application of a neural network model for
glycemic prediction in critical care patients will provide
significant insight to glycemic excursions at points in
time where POC glucose values are not obtained. The
ability to predict glucose concentration during these
time domains would provide caregivers a means of
modifying insulin dosages and therapy for optimization
of glycemic control. The optimization of glycemic con-
trol in critical care trauma patients could reduce mor-
bidity, and mortality in these patients [1-5]. This is also
fundamentally true in cardiac surgery patients who were
used as part of the modeling process [6-8].
Figure 2 Real-time predictions generated using patient specific
model. conc. = concentration; mg = milligrams; dl = deciliter.
Figure 3 Real-time predictions generated using general model.
conc. = concentration; mg = milligrams; dl = deciliter.
Figure 4 Clark error grid of predictions generated by patient
specific model. mg = milligrams; dl = deciliter.
Figure 5 Clark error grid of predictions by general model.m g
= milligrams; dl = deciliter.
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cation and assessment of patient’s estimates of their
blood glucose levels compared with the value obtained
by a meter [12]. It was later used to compare the clinical
accuracy of blood glucose levels generated by meters/
monitors compared to reference, and it was utilized in
this report because it has become the gold standard for
blood glucose meter accuracy [13].
The utilization of this predictive model in real-time
bedside monitoring for intelligent/directed therapy
recommendation, guidance, and ultimately automation,
will provide caregivers a means of enhancing patient
safety and care. Furthermore, CGM identifies hypoglyce-
mic and hyperglycemic excursions where conventional
POC glucose values are not obtained, and results of this
investigation demonstrate the utility of CGM in the cri-
tical care trauma setting. For the patients with an
extended length of stay in the ICU, the results of this
investigation substantiate the position that a patient spe-
cific neural network model (generated and trained with
data from a single patient) may provide increased clini-
cal performance and safety at the bedside. Further clini-
cal trials will need to be pursued.
Conclusions
Utilization of CGM in this patient population is clini-
cally useful. Further investigation regarding the develop-
ment and optimization of the real-time implementation
of the neural network for prediction of glucose is
ongoing and warranted based on this preliminary report.
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